MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2-Reference-Cited by-同舟云学术

MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2

Published:2023-10 Issue:7 Volume:23 Page:e480-e490.e3
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mansoori Behnaz,Kiani Shiva,Mezajin Alireza Ashrafi,Zandi Pouyan,Banaie Homadokht,Rostamzadeh Davoud,Cho William C.,Duijf Pascal H.G.,Mansoori Behzad^ORCID,Baradaran Behzad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer;Fedele;Crit Rev Oncol Hematol,2015

3. Mechanisms for estrogen receptor expression in human cancer 11 medical and health sciences 1112 oncology and carcinogenesis 06 biological sciences 0604 genetics;Hua;Exp Hematol Oncol,2018

4. MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment;Kaboli;Pharmacol Res,2015

5. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process;Pan;Onco Targets Ther,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role and mechanism of HMGA2 in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-05-16

2. MiRNAs as Promising Therapeutic Targets for Breast Cancer;OBM Genetics;2024-02-26

3. HMGA2 promotes cancer metastasis by regulating epithelial–mesenchymal transition;Frontiers in Oncology;2024-02-01